Annual EBITDA
-$59.07 M
+$15.30 M+20.57%
December 31, 2022
Summary
- As of February 9, 2025, SURF annual EBITDA is -$59.07 million, with the most recent change of +$15.30 million (+20.57%) on December 31, 2022.
- During the last 3 years, SURF annual EBITDA has fallen by -$6.21 million (-11.75%).
Performance
SURF EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Quarterly EBITDA
-$23.09 M
-$4.60 M-24.90%
June 30, 2023
Summary
- As of February 9, 2025, SURF quarterly EBITDA is -$23.09 million, with the most recent change of -$4.60 million (-24.90%) on June 30, 2023.
- Over the past year, SURF quarterly EBITDA has increased by +$1.04 million (+4.31%).
Performance
SURF Quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
TTM EBITDA
-$83.75 M
+$1.04 M+1.23%
June 30, 2023
Summary
- As of February 9, 2025, SURF TTM EBITDA is -$83.75 million, with the most recent change of +$1.04 million (+1.23%) on June 30, 2023.
- Over the past year, SURF TTM EBITDA has dropped by -$24.77 million (-42.00%).
Performance
SURF TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
EBITDA Formula
EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization
SURF EBITDA Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +20.6% | +4.3% | -42.0% |
| 3 y3 years | -11.8% | -65.1% | -301.3% |
| 5 y5 years | -31.2% | -42.1% | -58.4% |
SURF EBITDA Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +25.9% | -419.6% | +4.5% | +58.0% | +1.2% |
| 5 y | 5-year | -192.5% | +25.9% | -133.8% | +4.5% | -231.1% | +1.2% |
| alltime | all time | -192.5% | +25.9% | -133.8% | +4.5% | -231.1% | +1.2% |
Surface Oncology EBITDA History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2023 | - | -$23.09 M(+24.9%) | -$83.75 M(-1.2%) |
| Mar 2023 | - | -$18.49 M(-8.0%) | -$84.79 M(+43.5%) |
| Dec 2022 | -$59.07 M(-20.6%) | -$20.10 M(-8.9%) | -$59.07 M(-4.7%) |
| Sep 2022 | - | -$22.07 M(-8.6%) | -$61.96 M(+5.1%) |
| Jun 2022 | - | -$24.13 M(-434.0%) | -$58.98 M(+11.3%) |
| Mar 2022 | - | $7.23 M(-131.4%) | -$53.01 M(-28.7%) |
| Dec 2021 | -$74.37 M(-216.5%) | -$22.99 M(+20.5%) | -$74.37 M(-537.6%) |
| Sep 2021 | - | -$19.08 M(+5.0%) | $17.00 M(-23.4%) |
| Jun 2021 | - | -$18.17 M(+28.6%) | $22.18 M(-15.9%) |
| Mar 2021 | - | -$14.13 M(-120.7%) | $26.36 M(-58.7%) |
| Dec 2020 | $63.86 M | $68.38 M(-592.0%) | $63.86 M(-461.5%) |
| Sep 2020 | - | -$13.90 M(-0.6%) | -$17.66 M(-15.4%) |
| Jun 2020 | - | -$13.98 M(-159.8%) | -$20.87 M(-16.4%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2020 | - | $23.37 M(-277.7%) | -$24.95 M(-52.8%) |
| Dec 2019 | -$52.86 M(+577.3%) | -$13.15 M(-23.1%) | -$52.86 M(+17.7%) |
| Sep 2019 | - | -$17.10 M(-5.3%) | -$44.93 M(-1.3%) |
| Jun 2019 | - | -$18.07 M(+298.2%) | -$45.52 M(+4.1%) |
| Mar 2019 | - | -$4.54 M(-13.0%) | -$43.71 M(+460.0%) |
| Dec 2018 | -$7.80 M(-82.7%) | -$5.22 M(-70.5%) | -$7.80 M(-58.7%) |
| Sep 2018 | - | -$17.70 M(+8.9%) | -$18.92 M(+24.2%) |
| Jun 2018 | - | -$16.26 M(-151.8%) | -$15.23 M(+189.2%) |
| Mar 2018 | - | $31.36 M(-292.1%) | -$5.27 M(-88.3%) |
| Dec 2017 | -$45.03 M(+154.8%) | -$16.33 M(+16.5%) | -$45.03 M(+56.9%) |
| Sep 2017 | - | -$14.01 M(+122.7%) | -$28.70 M(+95.4%) |
| Jun 2017 | - | -$6.29 M(-25.1%) | -$14.69 M(+74.9%) |
| Mar 2017 | - | -$8.40 M | -$8.40 M |
| Dec 2016 | -$17.67 M | - | - |
FAQ
- What is Surface Oncology annual EBITDA?
- What is the all time high annual EBITDA for Surface Oncology?
- What is Surface Oncology annual EBITDA year-on-year change?
- What is Surface Oncology quarterly EBITDA?
- What is the all time high quarterly EBITDA for Surface Oncology?
- What is Surface Oncology quarterly EBITDA year-on-year change?
- What is Surface Oncology TTM EBITDA?
- What is the all time high TTM EBITDA for Surface Oncology?
- What is Surface Oncology TTM EBITDA year-on-year change?
What is Surface Oncology annual EBITDA?
The current annual EBITDA of SURF is -$59.07 M
What is the all time high annual EBITDA for Surface Oncology?
Surface Oncology all-time high annual EBITDA is $63.86 M
What is Surface Oncology annual EBITDA year-on-year change?
Over the past year, SURF annual EBITDA has changed by +$15.30 M (+20.57%)
What is Surface Oncology quarterly EBITDA?
The current quarterly EBITDA of SURF is -$23.09 M
What is the all time high quarterly EBITDA for Surface Oncology?
Surface Oncology all-time high quarterly EBITDA is $68.38 M
What is Surface Oncology quarterly EBITDA year-on-year change?
Over the past year, SURF quarterly EBITDA has changed by +$1.04 M (+4.31%)
What is Surface Oncology TTM EBITDA?
The current TTM EBITDA of SURF is -$83.75 M
What is the all time high TTM EBITDA for Surface Oncology?
Surface Oncology all-time high TTM EBITDA is $63.86 M
What is Surface Oncology TTM EBITDA year-on-year change?
Over the past year, SURF TTM EBITDA has changed by -$24.77 M (-42.00%)